FIELD: medicine.
SUBSTANCE: invention relates to method of obtaining medication on the basis of biologically active substance, which includes binding biologically active substance to neutral carrier, as neutral carrier metal or semiconductor nanoparticles are used, and as biologically active substance used is bacteriorodopsin in therapeutically efficient amount, whose molecules are linked to nanoparticle surface with formation of ligand shell.
EFFECT: obtained nanoparticles ensure efficient transportation of bacteriorodopsin into cells and tissues.
10 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NANOCOMPOSITE MATERIAL | 2007 |
|
RU2332352C1 |
| FORMING METHOD OF SURFACE OF SYNTHESISED NANOPARTICLES | 2007 |
|
RU2364471C1 |
| METHOD OF NANOCOMPOSITE OPTICAL PROPERTIES CONTROL | 2007 |
|
RU2332697C1 |
| METHOD FOR PREPARATION OF NANOPARTICLES WITH MODIFIED LIGAND SHELL | 2007 |
|
RU2367512C1 |
| METHOD OF OBJECT PROTECTION AGAINST FORGERY AND METHOD OF AUTHENTICITY CONTROL OF OBJECT PROTECTED AGAINST FORGERY | 2006 |
|
RU2329155C2 |
| METHOD OF MARKING THE OBJECT IN ANTI-COUNTERFEIT PROTECTION AND PHOTOCHROME INK | 2017 |
|
RU2662813C1 |
| METHOD OF PRODUCTION OF MOLECULAR OXYGEN | 2005 |
|
RU2283899C1 |
| METHOD OF MARKING AND CONTROLLING AUTHENTICITY IN PROTECTION AGAINST FORGING | 2008 |
|
RU2411135C2 |
| PHOTOSENSITIVE SECURITY MARK FOR VISUAL IDENTIFICATION | 2018 |
|
RU2679536C1 |
| METHOD OF PRODUCING COLLOIDAL QUANTUM DOTS FOR USE IN MEDICAL DIAGNOSTICS | 2022 |
|
RU2809097C1 |
